Dr. Mustafa Abugideiri, MD

Dr. Abugideiri practices at Inova Fairfax Hospital - Unit in Falls Church, Virginia.

Dr. Abugideiri's NPI, 1730576455, was assigned on April 21, 2015. Dr. Abugideiri graduated from George Washington University School of Medicine in 2015. Dr. Abugideiri holds North Carolina license 202000782.

Dr. Abugideiri's primary practice is Inova Fairfax Hospital - Unit, at 3300 Gallows Rd, Falls Church, VA 22046 in Falls Church City. The practice phone is (703) 698-3659.

Dr. Abugideiri's primary practice is Inova Fairfax Hospital - Unit in Falls Church, Virginia. Dr. Abugideiri is also affiliated with Inova Fairfax Hospital. The medical group on file is Radiation Oncology Associates of Northern Virginia. Dmand AI also links Dr. Abugideiri to 4 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Abugideiri practices, 7 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Abugideiri's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Abugideiri is licensed in North Carolina.

CMS data shows 2,520 Medicare services from Dr. Abugideiri across 18 procedure codes in 2024, for 602 Medicare patients. Medicare paid $182,169 for them.

CMS counts 602 Medicare patients who saw Dr. Abugideiri in 2024. The largest group is 65 to 74, with 269 patients. 75% of them have cancer, and 75% have high blood pressure. 5% are also on Medicaid. Their average risk score is 1.57, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Abugideiri's median patient age at 68, with 38% women.

In 2024, Dr. Abugideiri wrote 89 Medicare Part D claims for 50 patients. 92% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $220 in total drug cost. In 2023, CMS named 47 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Abugideiri for performance year 2024, reported as part of a group. Dr. Abugideiri accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Abugideiri as offering telehealth.

Dmand AI links 12 papers to Dr. Abugideiri, published from 2014 to 2021. 2019 was the busiest year, with 3. The most frequent topics are Prostatic Neoplasms, Radiosurgery and Radiotherapy Planning, Computer-Assisted. Dr. Abugideiri has published most often in Pract Radiat Oncol. Dr. Abugideiri's most frequent co-authors are Sibo Tian, MD, Robert Henry Press, MD and Matthew Jeffrey Ferris, MD.

CMS Open Payments shows 26 general payments to Dr. Abugideiri from 7 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 100% of the total. Teleflex LLC paid the most, $286.

Dr. Abugideiri graduated from George Washington University School of Medicine in 2015.